Benefits of Combined Phage-Antibiotic Therapy for the Control of Antibiotic-Resistant Bacteria: A Literature Review

Overview

Journal Antibiotics (Basel)

Specialty Pharmacology

Date 2022 Jul 27

PMID 35884092

Authors

Kevin Diallo

Alain Dublanchet

Affiliations

Soon will be listed here.

Abstract

With the increase in bacterial resistance to antibiotics, more and more therapeutic failures are being reported worldwide. The market for antibiotics is now broken due to the high cost of developing new molecules. A promising solution to bacterial resistance is combined phage-antibiotic therapy, a century-old method that can potentiate existing antibiotics by prolonging or even restoring their activity against specific bacteria. The aim of this literature review was to provide an overview of different phage-antibiotic combinations and to describe the possible mechanisms of phage-antibiotic synergy.

Citing Articles

Oral bacteriophages and their potential as adjunctive treatments for periodontitis: a narrative review.

Kabwe M, Tucci J, Darby I, Dashper S J Oral Microbiol. 2025; 17(1):2469890.

PMID: 40013014 PMC: 11864011. DOI: 10.1080/20002297.2025.2469890.

The Combination of Phage Therapy and β-Lactam Antibiotics for the Effective Treatment of Infections.

Moryl M, Szychowska P, Dziag J, Rozalski A, Torzewska A Int J Mol Sci. 2025; 26(1.

PMID: 39795870 PMC: 11719584. DOI: 10.3390/ijms26010011.

Overview of Phage Defense Systems in Bacteria and Their Applications.

Xu X, Gu P Int J Mol Sci. 2025; 25(24.

PMID: 39769080 PMC: 11676413. DOI: 10.3390/ijms252413316.

Advancing Phage Therapy: A Comprehensive Review of the Safety, Efficacy, and Future Prospects for the Targeted Treatment of Bacterial Infections.

Palma M, Qi B Infect Dis Rep. 2024; 16(6):1127-1181.

PMID: 39728014 PMC: 11675988. DOI: 10.3390/idr16060092.

Bacteriophage treatment is effective against carbapenem-resistant (KPC) in a neutropenic murine model of gastrointestinal translocation and renal infection.

Zagaliotis P, Michalik-Provasek J, Mavridou E, Naing E, Vizirianakis I, Chatzidimitriou D Antimicrob Agents Chemother. 2024; 69(2):e0091924.

PMID: 39704532 PMC: 11823626. DOI: 10.1128/aac.00919-24.

References

Malik D, Sokolov I, Vinner G, Mancuso F, Cinquerrui S, Vladisavljevic G . Formulation, stabilisation and encapsulation of bacteriophage for phage therapy. Adv Colloid Interface Sci. 2017; 249:100-133. DOI: 10.1016/j.cis.2017.05.014. View

Lu T, Collins J . Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy. Proc Natl Acad Sci U S A. 2009; 106(12):4629-34. PMC: 2649960. DOI: 10.1073/pnas.0800442106. View

Chan B, Turner P, Kim S, Mojibian H, Elefteriades J, Narayan D . Phage treatment of an aortic graft infected with . Evol Med Public Health. 2018; 2018(1):60-66. PMC: 5842392. DOI: 10.1093/emph/eoy005. View

Kortright K, Chan B, Koff J, Turner P . Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria. Cell Host Microbe. 2019; 25(2):219-232. DOI: 10.1016/j.chom.2019.01.014. View

EDLINGER E . [Antibiotics and bacteriophage lysis. V. Fixation and multiplication of twort staphylococcic phage in the presence of streptomycin]. Ann Inst Pasteur (Paris). 1950; 79(3):282-7. View

ZILISTEANU C, Filotti A, MINTZER-MORGENSTERN L, GHYKA G . [Association of bacteriophage with antibiotic therapy for the sterilization of carriers of dysentery bacilli]. Arch Roum Pathol Exp Microbiol. 1965; 24(4):1021-8. View

FAGUET M, Nicolle P . Inhibition of bacteriophage lysis by penicillin; lifting of this inhibition by penicillinase. Ann Inst Pasteur (Paris). 1947; 73(11):1150-4. View

Tagliaferri T, Jansen M, Horz H . Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy. Front Cell Infect Microbiol. 2019; 9:22. PMC: 6387922. DOI: 10.3389/fcimb.2019.00022. View

Chaudhry W, Concepcion-Acevedo J, Park T, Andleeb S, Bull J, Levin B . Synergy and Order Effects of Antibiotics and Phages in Killing Pseudomonas aeruginosa Biofilms. PLoS One. 2017; 12(1):e0168615. PMC: 5226664. DOI: 10.1371/journal.pone.0168615. View

10.

Yilmaz C, Colak M, Coskun Yilmaz B, Ersoz G, Kutateladze M, Gozlugol M . Bacteriophage therapy in implant-related infections: an experimental study. J Bone Joint Surg Am. 2013; 95(2):117-25. DOI: 10.2106/JBJS.K.01135. View

11.

Chhibber S, Kaur T, Kaur S . Co-therapy using lytic bacteriophage and linezolid: effective treatment in eliminating methicillin resistant Staphylococcus aureus (MRSA) from diabetic foot infections. PLoS One. 2013; 8(2):e56022. PMC: 3572146. DOI: 10.1371/journal.pone.0056022. View

12.

Rahman M, Kim S, Kim S, Seol S, Kim J . Characterization of induced Staphylococcus aureus bacteriophage SAP-26 and its anti-biofilm activity with rifampicin. Biofouling. 2011; 27(10):1087-93. DOI: 10.1080/08927014.2011.631169. View

13.

Coulter L, McLean R, Rohde R, Aron G . Effect of bacteriophage infection in combination with tobramycin on the emergence of resistance in Escherichia coli and Pseudomonas aeruginosa biofilms. Viruses. 2014; 6(10):3778-86. PMC: 4213561. DOI: 10.3390/v6103778. View

14.

Bleibtreu A, Fevre C, Robert J, Haddad E, Caumes E, Lantieri L . Combining bacteriophages and dalbavancin for salvage therapy of complex Staphylococcus aureus extradural empyema. Med Mal Infect. 2020; 50(5):458-459. DOI: 10.1016/j.medmal.2020.02.004. View

15.

ZILISTEANU C, Ionescu H, MINTZER L . [Treatment of urinary infections with bacteriophage-autovaccine-antibiotics]. Arch Roum Pathol Exp Microbiol. 1971; 30(2):195-207. View

16.

Stachurska X, Roszak M, Jablonska J, Mizielinska M, Nawrotek P . Double-Layer Agar (DLA) Modifications for the First Step of the Phage-Antibiotic Synergy (PAS) Identification. Antibiotics (Basel). 2021; 10(11). PMC: 8614717. DOI: 10.3390/antibiotics10111306. View

17.

Stone E, Campbell K, Grant I, McAuliffe O . Understanding and Exploiting Phage-Host Interactions. Viruses. 2019; 11(6). PMC: 6630733. DOI: 10.3390/v11060567. View

18.

Manohar P, Loh B, Athira S, Nachimuthu R, Hua X, Welburn S . Secondary Bacterial Infections During Pulmonary Viral Disease: Phage Therapeutics as Alternatives to Antibiotics?. Front Microbiol. 2020; 11:1434. PMC: 7358648. DOI: 10.3389/fmicb.2020.01434. View

19.

Lin D, Koskella B, Lin H . Phage therapy: An alternative to antibiotics in the age of multi-drug resistance. World J Gastrointest Pharmacol Ther. 2017; 8(3):162-173. PMC: 5547374. DOI: 10.4292/wjgpt.v8.i3.162. View

20.

Liu N, Lewis C, Zheng W, Fu Z . Phage Cocktail Therapy: Multiple Ways to Suppress Pathogenicity. Trends Plant Sci. 2020; 25(4):315-317. DOI: 10.1016/j.tplants.2020.01.013. View